SHPH: Shuttle Pharmaceuticals Holdings, Inc. Company Value to Net Income

Corporate emblem and logo of Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Market fluctuations in Shuttle Pharmaceuticals (SHPH) shares on GURU.Markets, where the indicator stands at -2.40, reflect the price action of the developer of radiation therapy enhancement agents. Shuttle Pharmaceuticals is currently conducting clinical trials, which is temporarily increasing laboratory testing expenses. Future certification will enable the integration of the product into global oncology center protocols, ensuring massive profits with low distribution costs.

SHPH - shuttlepharma.com Price to Earnings Ratio over the range 04/28/2023 - 11/10/2026

Comprehensive metric breakdowns and analytics for Shuttle Pharma (SHPH)

- share price and expert price forecast:
Price Performance Chart shuttlepharma.com|SHPH - Consensus Target
- market capitalization information:
Market Value Shuttle Pharmaceuticals Holdings|SHPH - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Shuttle Pharmaceuticals|SHPH - Company Book Value|Market Value to Book Value shuttlepharma.com|SHPH - Company Total Assets
- debt and solvency information:
Total Debt to Capital Shuttle Pharmaceuticals|SHPH - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Shuttle Pharmaceuticals Inc|SHPH - Company Debts|Debt to Book Value Ratio Shuttle Pharmaceuticals Holdings|SHPH - Company Long-Term Debt|Short-Term Debt Volume Shuttle Pharmaceuticals|Intermediate Coverage Ratio shuttlepharma.com
- earnings and market ratios statistics:
SHPH - Net Income|Projected Future Earnings Shuttle Pharmaceuticals|SHPH - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Shuttle Pharmaceuticals Holdings, Inc.|SHPH - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Shuttle Pharmaceuticals Holdings|SHPH - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Shuttle Pharmaceuticals|SHPH - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months shuttlepharma.com|SHPH - Net earnings per share growth this year|Expected earnings per share trend next year Shuttle Pharmaceuticals
Comprehensive company analysis:shuttlepharma.com SHPH
Core merchandise of Shuttle Pharmaceuticals

The fundamental risks of Shuttle Pharmaceuticals (SHPH) require a precise valuation of the business relative to its earnings. For a biotech developer of brain cancer therapies, this task is complicated by a dependency on clinical trial stages. By analyzing the company's weighted average P/E, an investor determines the payback period of invested capital through net income. This chart measures investment density and the issuer's degree of maturity. Consistently low values may signal stagnating growth potential.

Analysis of competing companies

CNSP: Company Value to Net Income